We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs.
- Authors
Loughlin, Laura; Hellyer, Thomas P.; White, P. Lewis; McAuley, Danny F.; Morris, Andrew Conway; Posso, Raquel B.; Richardson, Malcolm D.; Denning, David W.; Simpson, A. John; McMullan, Ronan; Conway Morris, Andrew
- Abstract
Rationale:Aspergillus infection in patients with suspected ventilator-associated pneumonia remains uncharacterized because of the absence of a disease definition and limited access to sensitive diagnostic tests.Objectives: To estimate the prevalence and outcomes of Aspergillus infection in adults with suspected ventilator-associated pneumonia.Methods: Two prospective UK studies recruited 360 critically ill adults with new or worsening alveolar shadowing on chest X-ray and clinical/hematological parameters supporting suspected ventilator-associated pneumonia. Stored serum and BAL fluid were available from 194 nonneutropenic patients and underwent mycological testing. Patients were categorized as having probable Aspergillus infection using a definition comprising clinical, radiological, and mycological criteria. Mycological criteria included positive histology or microscopy, positive BAL fluid culture, galactomannan optical index of 1 or more in BAL fluid or 0.5 or more in serum.Measurements and Main Results: Of 194 patients evaluated, 24 met the definition of probable Aspergillus infection, giving an estimated prevalence of 12.4% (95% confidence interval, 8.1-17.8). All 24 patients had positive galactomannan in serum (n = 4), BAL fluid (n = 16), or both (n = 4); three patients cultured Aspergillus sp. in BAL fluid. Patients with probable Aspergillus infection had a significantly longer median duration of critical care stay (25.5 vs. 15.5 d, P = 0.02). ICU mortality was numerically higher in this group, although this was not statistically significant (33.3% vs. 22.8%; P = 0.23).Conclusions: The estimated prevalence for probable Aspergillus infection in this geographically dispersed multicenter UK cohort indicates that this condition should be considered when investigating patients with suspected ventilator-associated pneumonia, including patient groups not previously recognized to be at high risk of aspergillosis.
- Subjects
DNA analysis; NONPARAMETRIC statistics; INTENSIVE care units; RESEARCH; CHEST X rays; RESEARCH methodology; EVALUATION research; MEDICAL cooperation; PULMONARY aspergillosis; RISK assessment; CATASTROPHIC illness; COMPARATIVE studies; CRITICAL care medicine; DISEASE prevalence; RESEARCH funding; VENTILATOR-associated pneumonia; POLYMERASE chain reaction; DEMOGRAPHY; ASPERGILLUS; LONGITUDINAL method; COMORBIDITY
- Publication
American Journal of Respiratory & Critical Care Medicine, 2020, Vol 202, Issue 8, p1125
- ISSN
1073-449X
- Publication type
journal article
- DOI
10.1164/rccm.202002-0355OC